Profilo
Doug Mendenhall worked as the Chief Scientific Officer at Patheon, Inc. from 2009 to 2010.
He received his undergraduate degree from the University of Washington and his graduate and doctorate degrees from the University of Kansas.
Precedenti posizioni note di Doug Mendenhall
| Società | Posizione | Fine |
|---|---|---|
| PATHEON, INC. | Direttore Tecnico/Scientifico/R&S | 15/04/2010 |
Formazione di Doug Mendenhall
| University of Kansas | Doctorate Degree |
| University of Washington | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Patheon, Inc.
 Patheon, Inc. Pharmaceuticals: MajorHealth Technology Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Doug Mendenhall
